Goldstein Advisors’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,288
Closed -$201K 213
2025
Q2
$201K Sell
1,288
-1,092
-46% -$173K 0.03% 190
2025
Q1
$392K Buy
2,380
+10
+0.4% +$1.66K 0.06% 111
2024
Q4
$386K Sell
2,370
-377
-14% -$67.4K 0.06% 111
2024
Q3
$537K Sell
2,747
-129
-4% -$23.8K 0.08% 83
2024
Q2
$499K Buy
2,876
+244
+9% +$40.6K 0.08% 81
2024
Q1
$445K Buy
2,632
+239
+10% +$44.8K 0.08% 85
2023
Q4
$472K Sell
2,393
-4
-0.2% -$708 0.08% 105
2023
Q3
$417K Buy
2,397
+43
+2% +$7.81K 0.09% 81
2023
Q2
$405K Sell
2,354
-21
-0.9% -$3.63K 0.08% 85
2023
Q1
$395K Buy
2,375
+169
+8% +$27.7K 0.09% 89
2022
Q4
$323K Buy
+2,206
New +$326K 0.08% 95

Other funds holding ZTS

Goldstein Advisors's ZTS Position: Q3 2025 in Review

Goldstein Advisors sold out of Zoetis (ZTS) in Q3 2025, closing a stake of 1,288 shares — an estimated $201K sold.

Goldstein Advisors first reported a position in ZTS in Q4 2022 and held it in 11 quarters. The position peaked at $537K in Q3 2024. 1,805 funds tracked by Wall St. Rank hold ZTS as of Q3 2025.

  • Goldstein Advisors reported no remaining Zoetis position as of Q3 2025 after selling out during the quarter.
  • Goldstein Advisors sold 1,288 Zoetis shares in Q3 2025, an estimated $201K.
  • Goldstein Advisors first reported a position in Zoetis in Q4 2022 and held it in 11 quarters.
  • Goldstein Advisors's Zoetis position peaked at $537K in Q3 2024.
  • 1,805 funds tracked by Wall St. Rank held Zoetis as of Q3 2025.

Based on Goldstein Advisors's 13F filing for Q3 2025, filed 21 Oct 2025.